Human Placenta-Derived Mesenchymal Stem Cells Reduce Mortality and Hematoma Size in a Rat Intracerebral Hemorrhage Model in an Acute Phase
Intracerebral hemorrhage (ICH) is a critical disease, highly associated with mortality and morbidity. Several studies have demonstrated the beneficial effect of mesenchymal stem cells (MSCs) on ICH, mostly focused on their mid-to-long-term effect. Acute hematoma expansion is one of the most importan...
Saved in:
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-01-01
|
Series: | Stem Cells International |
Online Access: | http://dx.doi.org/10.1155/2018/1658195 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832552349641474048 |
---|---|
author | Bo Young Choi Ok Joon Kim Sae-Hong Min Jeong Hyun Jeong Sang Won Suh Tae Nyoung Chung |
author_facet | Bo Young Choi Ok Joon Kim Sae-Hong Min Jeong Hyun Jeong Sang Won Suh Tae Nyoung Chung |
author_sort | Bo Young Choi |
collection | DOAJ |
description | Intracerebral hemorrhage (ICH) is a critical disease, highly associated with mortality and morbidity. Several studies have demonstrated the beneficial effect of mesenchymal stem cells (MSCs) on ICH, mostly focused on their mid-to-long-term effect. Acute hematoma expansion is one of the most important prognostic factors of ICH. We hypothesized that MSCs would decrease mortality and hematoma size in acute ICH, based on the findings of a few recent researches reporting their effect on blood-brain barrier and endothelial integrity. Rat ICH models were made using bacterial collagenase. One hour after ICH induction, the rats were randomly divided into MSC-treated and control groups. Mortality, hematoma volume, ventricular enlargement, brain edema, and degenerating neuron count were compared at 24 hours after ICH induction. Expression of tight junction proteins (ZO-1, occludin) and coagulation factor VII mRNA was also compared. Mortality rate (50% versus 8.3%), hematoma size, ventricular size, hemispheric enlargement, and degenerating neuron count were significantly lower in the MSC-treated group (p=0.034, 0.038, 0.001, 0.022, and <0.001, resp.), while the expression of ZO-1 and occludin was higher (p=0.007 and 0.012). Administration of MSCs may prevent hematoma expansion in the hyperacute stage of ICH and decrease acute mortality by enhancing the endothelial integrity of cerebral vasculature. |
format | Article |
id | doaj-art-3f011df376714325add9ec30f11e1273 |
institution | Kabale University |
issn | 1687-966X 1687-9678 |
language | English |
publishDate | 2018-01-01 |
publisher | Wiley |
record_format | Article |
series | Stem Cells International |
spelling | doaj-art-3f011df376714325add9ec30f11e12732025-02-03T05:58:46ZengWileyStem Cells International1687-966X1687-96782018-01-01201810.1155/2018/16581951658195Human Placenta-Derived Mesenchymal Stem Cells Reduce Mortality and Hematoma Size in a Rat Intracerebral Hemorrhage Model in an Acute PhaseBo Young Choi0Ok Joon Kim1Sae-Hong Min2Jeong Hyun Jeong3Sang Won Suh4Tae Nyoung Chung5Department of Physiology, College of Medicine, Hallym University, Hallymdaehak-gil, Chuncheon 24252, Republic of KoreaDepartment of Neurology, CHA University School of Medicine, 59 Yatap-Ro, Bundang-Gu, Seongnam 13496, Republic of KoreaDepartment of Emergency Medicine, CHA University School of Medicine, 59 Yatap-Ro, Bundang-Gu, Seongnam 13496, Republic of KoreaDepartment of Physiology, College of Medicine, Hallym University, Hallymdaehak-gil, Chuncheon 24252, Republic of KoreaDepartment of Physiology, College of Medicine, Hallym University, Hallymdaehak-gil, Chuncheon 24252, Republic of KoreaDepartment of Emergency Medicine, CHA University School of Medicine, 59 Yatap-Ro, Bundang-Gu, Seongnam 13496, Republic of KoreaIntracerebral hemorrhage (ICH) is a critical disease, highly associated with mortality and morbidity. Several studies have demonstrated the beneficial effect of mesenchymal stem cells (MSCs) on ICH, mostly focused on their mid-to-long-term effect. Acute hematoma expansion is one of the most important prognostic factors of ICH. We hypothesized that MSCs would decrease mortality and hematoma size in acute ICH, based on the findings of a few recent researches reporting their effect on blood-brain barrier and endothelial integrity. Rat ICH models were made using bacterial collagenase. One hour after ICH induction, the rats were randomly divided into MSC-treated and control groups. Mortality, hematoma volume, ventricular enlargement, brain edema, and degenerating neuron count were compared at 24 hours after ICH induction. Expression of tight junction proteins (ZO-1, occludin) and coagulation factor VII mRNA was also compared. Mortality rate (50% versus 8.3%), hematoma size, ventricular size, hemispheric enlargement, and degenerating neuron count were significantly lower in the MSC-treated group (p=0.034, 0.038, 0.001, 0.022, and <0.001, resp.), while the expression of ZO-1 and occludin was higher (p=0.007 and 0.012). Administration of MSCs may prevent hematoma expansion in the hyperacute stage of ICH and decrease acute mortality by enhancing the endothelial integrity of cerebral vasculature.http://dx.doi.org/10.1155/2018/1658195 |
spellingShingle | Bo Young Choi Ok Joon Kim Sae-Hong Min Jeong Hyun Jeong Sang Won Suh Tae Nyoung Chung Human Placenta-Derived Mesenchymal Stem Cells Reduce Mortality and Hematoma Size in a Rat Intracerebral Hemorrhage Model in an Acute Phase Stem Cells International |
title | Human Placenta-Derived Mesenchymal Stem Cells Reduce Mortality and Hematoma Size in a Rat Intracerebral Hemorrhage Model in an Acute Phase |
title_full | Human Placenta-Derived Mesenchymal Stem Cells Reduce Mortality and Hematoma Size in a Rat Intracerebral Hemorrhage Model in an Acute Phase |
title_fullStr | Human Placenta-Derived Mesenchymal Stem Cells Reduce Mortality and Hematoma Size in a Rat Intracerebral Hemorrhage Model in an Acute Phase |
title_full_unstemmed | Human Placenta-Derived Mesenchymal Stem Cells Reduce Mortality and Hematoma Size in a Rat Intracerebral Hemorrhage Model in an Acute Phase |
title_short | Human Placenta-Derived Mesenchymal Stem Cells Reduce Mortality and Hematoma Size in a Rat Intracerebral Hemorrhage Model in an Acute Phase |
title_sort | human placenta derived mesenchymal stem cells reduce mortality and hematoma size in a rat intracerebral hemorrhage model in an acute phase |
url | http://dx.doi.org/10.1155/2018/1658195 |
work_keys_str_mv | AT boyoungchoi humanplacentaderivedmesenchymalstemcellsreducemortalityandhematomasizeinaratintracerebralhemorrhagemodelinanacutephase AT okjoonkim humanplacentaderivedmesenchymalstemcellsreducemortalityandhematomasizeinaratintracerebralhemorrhagemodelinanacutephase AT saehongmin humanplacentaderivedmesenchymalstemcellsreducemortalityandhematomasizeinaratintracerebralhemorrhagemodelinanacutephase AT jeonghyunjeong humanplacentaderivedmesenchymalstemcellsreducemortalityandhematomasizeinaratintracerebralhemorrhagemodelinanacutephase AT sangwonsuh humanplacentaderivedmesenchymalstemcellsreducemortalityandhematomasizeinaratintracerebralhemorrhagemodelinanacutephase AT taenyoungchung humanplacentaderivedmesenchymalstemcellsreducemortalityandhematomasizeinaratintracerebralhemorrhagemodelinanacutephase |